PMID: 9436426Jan 22, 1998Paper

Introduction of rod-deleted dystrophin cDNA, delta DysM3, into mdx skeletal muscle using adenovirus vector

Nihon rinsho. Japanese journal of clinical medicine
Katsutoshi YuasaS I Takeda

Abstract

The 6.3 kb mini-dystrophin cDNA, has been successfully introduced in dystrophic mdx mouse and phenotypes of muscular dystrophy has been considerably improved. We generate a dystrophin cDNA construct deleted more for rod domain of minidystrophin, resulting only one rod repeat with two hinge segments, 3.7 kb delta DysM3. Recombinant adenovirus vector, Ax delta DysM3 has been made using COS-TPC method. 125 kDa delta DysM3 was expressed in the cultured skeletal muscle cells, when Ax delta DysM3 was infected. delta DysM3 can effectively accumulate in sarcolemma and considerably recover of dystrophin-associated proteins when transferred into skeletal muscle of mdx mouse. This small-sized rod-deleted dystrophin can be incorporated into adeno-associated virus vector, which was recently proven to be good tool to carry the gene into skeletal muscle.

Related Concepts

Related Feeds

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.